spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Sepracor 

 HSMN NewsFeed - 5 May 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 9 Mar 2020
Relmada Therapeutics Appoints CNS Specialist Thomas C. Wessel, M.D., Ph.D., as Executive Vice President, Head of Research and Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2018
Akero Therapeutics Appoints Mark Iwicki to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2018
Torque Announces Appointment of Immunotherapy Pioneer F. Stephen Hodi, MD, to Scientific Advisory Board and Alex Bruni as COO/ CFO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Jun 2018
BrainStorm Strengthens Executive Management Team with the Appointment of Susan Ward, Ph.D. and Joseph Petroziello
Regenerative Medicine Personnel
 HSMN NewsFeed - 31 Mar 2017
Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2016
RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 Feb 2016
Recro Pharma Appoints Fred Graff as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2015
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Oct 2015
Quartet Medicine Completes $23.25 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2014
Aileron Therapeutics Expands Senior Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Aug 2014
Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 9 Jul 2014
RestorGenex Announces Management Changes
Biopharmaceuticals Dermatology Ophthalmology Personnel
 HSMN NewsFeed - 16 Apr 2014
Dyax Corp. Announces Appointment of Todd Bazemore as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2014
Chimerix Appoints Lisa Ricciardi to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2013
Neos Therapeutics, Inc. Announces the Appointment of Vipin K. Garg, Ph.D. as Chief Executive Officer and Board Director
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Sep 2013
BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2013
RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2013
Ironwood Pharmaceuticals Promotes Dr. Mark Currie to Senior Vice President, Chief Scientific Officer, and President of R&D
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2012
Blend Therapeutics Appoints Mark Iwicki as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2012
Cubist Pharmaceuticals Announces Senior Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2012
Auxilium Announces Appointments to Enhance Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2011
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2011
Neurologix Appoints Adrian Adams as Company Chairman and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 9 Aug 2011
MAP Pharmaceuticals Appoints Frederick H. Graff Vice President, Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jun 2011
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2010
Euthymics Bioscience, Inc. Names Biotech Executive Timothy J. Barberich to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Jul 2010
Sepracor Inc. to Become Sunovion Pharmaceuticals Inc.
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2010
Dendreon Appoints Richard Ranieri as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2010
Inspire Appoints Andrew Koven as Executive Vice President and Chief Administrative and Legal Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2010
Human Genome Sciences Appoints David P. Southwell Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2010
Inspire Names Adrian Adams as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2010
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 6 Jan 2010
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Dec 2009
Sepracor Granted Patent Term Extension for LUNESTA(R) and Provides Update on LUNESTA Pediatric Studies
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Sep 2009
Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Jul 2009
CombinatoRx and Neuromed Sign Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 20 Jan 2009
GeoPharma Announces Settlement of Clarinex(r) (Desloratadine) ANDA Patent Litigation With Schering and Sepracor
Biopharmaceuticals Litigation
 HSMN NewsFeed - 24 Oct 2008
European Medicines Agency (EMEA) Issues Positive Opinion For LUNIVIA(R) (Eszopiclone) Marketing Authorization Application (MAA) In Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Sep 2008
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Aug 2008
Somaxon Pharmaceuticals Announces the Appointment of Senior Commercial Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2008
MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2008
Gemin X Pharmaceuticals Appoints Peter R. Dolan to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jun 2008
Sepracor Announces Phase III Data for Eslicarbazepine Acetate Presented at Ninth Eilat Conference on New Anti-Epileptic Drugs
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Jun 2008
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2008
Cortex Pharmaceuticals Announces Management Changes
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 May 2008
Sepracor Names Robert F. Scumaci as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
David P. Southwell to Resign as Chief Financial Officer of Sepracor
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2008
LUNESTA(R) Study of Patients with Insomnia and Co-Morbid Generalized Anxiety Disorder (GAD) Published in Archives of General Psychiatry
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2008
Sepracor and Arrow Sign Global License and Development Agreement Covering Technology to Enhance Ciclesonide and BROVANA(R) Franchises
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 May 2008
Sepracor Announces Final Settlement of XOPENEX(R) Inhalation Solution Patent Infringement Litigation with Breath Limited
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 May 2008
Sepracor and Arrow Sign Global License and Development Agreement for XOPENEX(R)/Ipratropium Inhalation Solution Combination
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 May 2008
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Apr 2008
HeartWare Appoints Timothy J. Barberich to Board of Directors
Devices Personnel
 HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Strengthens Its Board of Directors with Industry Leaders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2008
Inotek Focuses Resources on Clinical Programs, Adds to Executive Management Team and Consolidates Operations in Massachusetts
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2008
Sepracor Presents OMNARIS(TM) HFA Nasal Aerosol Large-Scale Phase II Study Data at American Academy of Allergy Asthma and Immunology (AAAAI)
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2008
Sepracor Presents Safety Data on OMNARIS(TM)AQ and OMNARIS(TM) HFA Nasal Sprays at American Academy of Allergy Asthma and Immunology (AAAAI)
Biopharmaceuticals
 HSMN NewsFeed - 4 Mar 2008
Momenta Pharmaceuticals Appoints Dr. James M. Roach as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jan 2008
Sepracor Acquires Exclusive U.S. Rights to Nycomed's ALVESCO(R) HFA and OMNARIS(TM) AQ Products as Well as Ciclesonide Pipeline
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 23 Jan 2008
Myriad Genetics, Inc. Expands Commercial and Clinical Infrastructure
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2008
Pharmos Corporation Announces Board and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2008
Timothy J. Barberich to Resign as Executive Chairman of Sepracor and Will Continue to Serve as Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2008
Sepracor Inc. and Bial Announce Exclusive Licensing Agreement for Development and Commercialization of Anti-Epileptic Compound in United States and Canada
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 27 Nov 2007
BIND Biosciences, Inc. Closes $16M Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Nov 2007
Sepracor Inc. Announces Appointment of Lisa Ricciardi as Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2007
Sepracor Inc. Announces the Establishment of a Unique Product-Specific Billing Code (or J-Code) for BROVANA(R)
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 15 Oct 2007
Sepracor Announces Senior Management Appointments as Part of Commercial Re-Organization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2007
Sepracor Inc. and GlaxoSmithKline Announce International Alliance for Commercialization of LUNIVIA(R) (LUNESTA(R) in U.S.)
Biopharmaceuticals
 HSMN NewsFeed - 27 Jul 2007
Sepracor Submits LUNIVIA(R) (LUNESTA(R) in U.S.) Marketing Authorization Application (MAA) for Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Jul 2007
Sepracor Inc. and Eisai Co. Ltd. Announce Partnership for Development and Commercialization of LUNESTA(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 17 Jul 2007
William P. Kane Named Vice President, Commercial Operations for Keryx Biopharmaceuticals, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2007
Barr Confirms Patent Challenge of Xopenex(R) Inhalation Solution, 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Jun 2007
Sepracor Issues Statement Regarding CMS Medicare Part B Reimbursement Change for XOPENEX(R) Inhalation Solution
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 15 May 2007
Sepracor Announces Management Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2007
BROVANA(TM) Inhalation Solution Now Available by Prescription for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2007
Artisan Pharma, Inc. Hires Senior Clinical and Regulatory Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Feb 2007
Cardiome Announces Management Appointments
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 21 Feb 2007
Sepracor Announces Publication of Additional Data from Lunesta(R) Insomnia-Depression Study in the Journal of Clinical Sleep Medicine
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2006
Results of Sepracor's LUNESTA(R) Next-Day Driving Study in Patients with Primary Insomnia Presented at American College of Neuropsychopharmacology Meeting
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2006
Data Show Sepracor's Lunesta(R) Improved Insomnia in Patients with Co-Existing Generalized Anxiety Disorder
Biopharmaceuticals
 HSMN NewsFeed - 4 Dec 2006
Advanced Magnetics, Inc. Announces Appointment of Timothy G. Healey as Senior Vice President of Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2006
LUNESTA(R) Perimenopause-Menopause Study Published in Journal of Obstetrics and Gynecology
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
XOPENEX HFA(R) Data Presented at American College of Allergy, Asthma and Immunology Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2006
Data for XOPENEX(R) Brand of Levalbuterol Presented at American College of Chest Physicians Annual Conference
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2006
BROVANA(TM) (Arformoterol Tartrate) Inhalation Solution Study Data Presented at American College of Chest Physicians Annual Conference
Biopharmaceuticals
 HSMN NewsFeed - 13 Oct 2006
Pfizer Names Senior Executive to Head Expanded Worldwide Licensing and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2006
Newly Published Data Show Efficacy and Safety of LUNESTA(R) in Elderly Patients with Insomnia
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2006
FDA Approves Sepracor's BROVANA(TM) (Arformoterol Tartrate) Inhalation Solution for Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Oct 2006
Regeneron Names Peter Powchik, M.D., Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2006
Sepracor Announces Presentation of LUNESTA(TM) Data at Associated Professional Sleep Societies 20th Anniversary Meeting
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 55

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 55 additional stories matching:
Sepracor
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.